GS-5816, a Once-Daily NS5A Inhibitor, Demonstrates Potent Antiviral Activity in Patients with Genotype 1, 2, 3, or 4 HCV Infection in a 3-Day Monotherapy StudyEric Lawitz, Steven J. Glass,Daniel Gruener,Bradley Freilich,John M. Hill,John O. Link,Polina German,Christy Hebner,Lingling Han,Diana M. Brainard,John McNally,William B. Smith,Suzanne Kim,Thomas C. Marbury, Jon Ruckle,Maribel Rodriguez-TorresHEPATOLOGY（2013）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
